21 May 2025
Cancers | 2024 Editor’s Choice Articles and Opening Special Issues Related to “Molecular Cancer Biology”

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some editor’s choice articles related to molecular cancer biology that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.
“Ocular Surface Side Effects of Novel Anticancer Drugs”
by Livio Vitiello, Filippo Lixi, Giulia Coco and Giuseppe Giannaccare
Cancers 2024, 16(2), 344; https://doi.org/10.3390/cancers16020344
Available online: https://www.mdpi.com/2072-6694/16/2/344
“Transcription Factors and Markers Related to Epithelial–Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers”
by Marta Pawlicka, Ewelina Gumbarewicz, Ewa Błaszczak and Andrzej Stepulak
Cancers 2024, 16(7), 1354; https://doi.org/10.3390/cancers16071354
Available online: https://www.mdpi.com/2072-6694/16/7/1354
“Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review”
by Shigekatsu Maekawa, Ryo Takata and Wataru Obara
Cancers 2024, 16(3), 523; https://doi.org/10.3390/cancers16030523
Available online: https://www.mdpi.com/2072-6694/16/3/523
“Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer”
by Maciej Jaromin, Tomasz Konecki and Piotr Kutwin
Cancers 2024, 16(7), 1366; https://doi.org/10.3390/cancers16071366
Available online: https://www.mdpi.com/2072-6694/16/7/1366
“Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications”
by Philip Salu and Katie M. Reindl
Cancers 2024, 16(6), 1213; https://doi.org/10.3390/cancers16061213
Available online: https://www.mdpi.com/2072-6694/16/6/1213
“CD44: A New Prognostic Marker in Colorectal Cancer?”
by Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna et al.
Cancers 2024, 16(8), 1569; https://doi.org/10.3390/cancers16081569
Available online: https://www.mdpi.com/2072-6694/16/8/1569
Special Issues:
“The Genomic Landscape of Gynecological Cancers”
Guest Editor: Dr. Tong Sun
Submission deadline: 1 October 2025
“Childhood Cancer in the Genomic Era: Experimental and Theoretical Approaches (2nd Edition)”
Guest Editor: Dr. George I. Lambrou
Submission deadline: 31 October 2025
“The Biology of Hepatocellular Carcinoma: Implications for Genomic and Immune Therapies (2nd Edition)”
Guest Editor: Prof. Dr. Naoshi Nishida
Submission deadline: 31 January 2026
“Novel Strategies to Fight Metastatic Breast Cancer”
Guest Editors: Prof. Dr. Fernando Schmitt and Prof. Dr. Nuno Vale
Submission deadline: 31 March 2026